Biodistribution of 188Re-Anti-cea Monoclonal Antibody (C50) in BALB/C Mice Model of Colon Cancer

金留根,邢春根,吾为一,刘增礼,吴锦昌
DOI: https://doi.org/10.3969/j.issn.1009-881x.2002.02.005
2002-01-01
Abstract:Objective To investigate the biodistribution of the 188 Re-anti-CEA monoclonal antibody (C50) in mice model of colon cancer and evaluate the guiding value of 188 Re-C50 in organism.Methods The BALB/C mice model of colon cancer were divided into 5 groups. 0.16mg 188 Re-C50 was injected into the tumor for each mouse. After injection radioimmunimaging was performed at 6,12,24,48 and 96 hours late. Then these mice were killed. Various specimens was taken and their radioactivities were counted.Results Satisfactory imaging was obtained at 12 hours after injection and the T/NT ratio was the highest at this point. At this time tumor/colon was 39.85±21.36, tumor/liver was 21.94±12.72 and tumor/blood was 16.38±9.69. As the time passed the radioactivities of tumor and non-tumor tissue declined ,but the T/NT ratio could be kept on a higher level even 48 hours late after injection. For example, tumor/liver of this time is 12.69±10.92l, tumor/blood 5.23±7.3.Conclusion 188 Re-C50 can combine with tumor antigenic determinant specifically in model of colon cancer. It has optional targeting effect.
What problem does this paper attempt to address?